SCHEMBL23716845

SCHEMBL23716845

COc1ccc(C(=O)OCCSc2ccc(C=O)c3c2=CCON=3)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APOBEC3A P31941 1/20 0.37
▸ APOBEC3G Q9HC16 1/20 0.37
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.34
▸ GAA P10253 1/20 0.34
▸ PKM P14618 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ PRKCA P17252 3/20 0.32
▸ RASGRP3 Q8IV61 3/20 0.32
▸ SLC2A1 P11166 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23716849 0.78 KMT2A (0.36) NPC1RAB9ASMN1; SMN2MAPTGAA
SCHEMBL10345791 0.65 ALDH1A1 (0.63) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL26424956 0.65 GSTP1 (0.42) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2
SCHEMBL11985689 0.64 MAPT (0.73) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2
SCHEMBL19214420 0.64 ALDH1A1 (0.61) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2
SCHEMBL26425058 0.64 GSTP1 (0.64) —
SCHEMBL12532605 0.63 NPC1 (0.67) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2
SCHEMBL12201118 0.62 NPC1 (0.54) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2
SCHEMBL27824110 0.61 SMN1; SMN2 (0.64) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL24370251 0.61 MAPT (0.56) APOBEC3AAPOBEC3GNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021155253-A1 ANAT INHIBITORS AND METHODS OF USE THEREOF Atomwise Inc. (US) 2021-08-05 — — WO disclosed
Send feedback